• English
  • தமிழ்
  • বাংলা
  • മലയാളം
  • ગુજરાતી
  • हिंदी
  • मराठी
  • Business

The Financial Express

  • Whatsapp Whatsapp Link
  • Facebook Facebook Link
  • Twitter Twitter Link
  • Linkedin Linkedin Link
Google News Follow
Watchlist
  • Home
  • Todays Paper
  • Business
  • Markets
  • Market Stats
  • Mutual Funds
  • Money
  • India
  • Tech
  • US News
  • Shorts
  • Stock Market LIVE
  • IPO News
  • Stock Insights
  • Defence Stocks
  • Finance Stocks
  • IT Stocks
  • Gold Rate
  • Silver Rate
  • Breakout Stocks
  • Home
  • Market
    • Stock Insights
    • Cryptocurrency
    • IPO News
    • Stock Market Quotes
    • Indices
    • Nifty 50
    • Sensex
    • Top Gainers
    • Top Losers
    • IPO Stats
  • Market Dashboard
  • Commodities
    • Gold Rate in India
    • Silver Rate in India
    • Petrol Rate in India
    • Diesel Rate in India
  • Opportunity Abroad
  • Money
    • Insurance
    • Income Tax
    • Mutual Funds News
    • MF Screener
  • Economy
  • Business
    • Brand Wagon
    • SME
    • Defence
    • Healthcare
  • Industry
    • Banking & Finance
  • India News
  • World News
  • Jobs-Career
  • Infrastructure
    • Railways
    • Aviation
    • Roadways
  • Auto
  • Life
    • Lifestyle
    • Entertainment
    • Technology
    • Travel & Tourism
    • Science
  • Sports
  • Opinion
  • Multimedia
    • Photos
    • Web Stories
  • Events
  • ePaper
  • Today’s Paper
  • About us
  • PRIVACY POLICY
  • TERMS AND CONDITIONS
  • Contact Us

  1. Business News
  2. About
  3. gsk

GSK

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
Q3FY25: GSK pharma's profit surges 4X to Rs 229 crore; Revenue up 18 percent
Q3FY25: GSK pharma’s profit surges 4X to Rs 229 crore; Revenue up 18 percent

In the vaccines segment, GSK maintained its leadership in the self-pay private market for Paediatric vaccines, the company stated.

February 14, 2025 16:42 IST
To defy shrinking lifespan, companies need to stay ahead of the curve and innovate: Deepak Parekh
To defy shrinking lifespan, companies need to stay ahead of the curve and innovate: Deepak Parekh

Statistics show about half a century ago, the average lifespan of a company was 60 years. Today, it has shrunk…

November 12, 2024 18:02 IST
GSK moves mRNA flu vaccine to late-stage trials following positive outcomes
GSK moves mRNA flu vaccine to late-stage trials following positive outcomes

In July, GSK bought partner CureVac out of their alliance on influenza and COVID-19 vaccine development, boosting its messenger RNA…

September 12, 2024 15:49 IST
GSK's COPD drug candidate shows significantly positive outcome in Phase III trial
GSK’s COPD drug candidate shows significantly positive outcome in Phase III trial

COPD is the third leading cause of death worldwide with exacerbations accounting for the greatest proportion of the total COPD…

September 9, 2024 17:26 IST
GSK takes full rights to COVID-19, influenza vaccines from CureVac
GSK takes full rights to COVID-19, influenza vaccines from CureVac

The partnership began in 2020 during the COVID-19 pandemic and saw the two companies work together to develop vaccines for…

July 5, 2024 10:46 IST
GSK, Aiolos, Asthma drug, experimental drug, healthcare news, pharma news,
GSK presents significantly positive outcomes of its vaccine against Shingles

A variety of factors can increase the risk of developing shingles, including advancing age and immunodeficiency or immunosuppression, as well…

May 15, 2024 17:55 IST
GSK, GSK vaccine, RSV, RSV treatment, healthcare news, pharma news,
GSK’s Arexvy label expansion will intensify competition with Pfizer’s Abrysvo in RSV space

The application is supported by positive trial results from a Phase III, placebo-controlled, observer-blind, randomized, multi-country immunogenicity clinical trial.

February 5, 2024 11:46 IST
GSK, Aiolos, Asthma drug, experimental drug, healthcare news, pharma news,
GSK to buy Asthma drug owner Aiolos for up to $1.4 billion

Walmsley said Monday that she’s watching for deals that would expand the UK company’s existing pipeline.

January 9, 2024 17:09 IST
GSK, cancer drug Jemperli, chemotherapy, endometrial cancer, gynaecologic cancer, latest healthcare news, latest news,
GSK says endometrial cancer drug meets overall survival goal in late-stage trial

British drugmaker GSK said on Monday its cancer drug Jemperli, when combined with chemotherapy.

October 30, 2023 18:23 IST
Pfizer, Pfizer Q3 results, quarter earnings, profit, revenue, EBITDA, appointment, resignation
Pfizer and GSK’s new RSV vaccines on track For $2 billion in sales

In the US alone, Murphy expects GSK to sell about $1.1 billion of its adult vaccine in 2023, while Pfizer…

October 4, 2023 08:00 IST
European Commission, GSK, RSV vaccine, healthcare news, pharma news,
GSK gets FDA approval for Jemperli use with chemo to treat Endometrial Cancer

GSK has invested heavily in the drug, also known as dostarlimab, and is seeking to eventually show it could be…

August 2, 2023 10:00 IST
GlobalData, biologics drugs, small molecules, venture, healthcare news, pharma news,
After BCG, a new TB vaccine enters the final trial phase; read on to know all about this ‘promising’ shot

Reportedly, this vaccine could save 8.5 million lives and prevent 76m cases of TB, over the next 25 years. The…

June 30, 2023 15:21 IST
European Commission, GSK, RSV vaccine, healthcare news, pharma news,
European Commission gives final nod to GSK’s RSV vaccine

RSV, a common contagious virus affecting the lungs and breathing passages, usually causes mild, cold-like symptoms but can also lead…

June 7, 2023 14:50 IST
Emcure Pharmaceuticals, iron deficiency, pregnancy, healthcare news, pharma news,
USFDA approves world’s first vaccine against life-threatening respiratory illness

According to a study published by the pharma major in February, the efficacy of this vaccine is at 82.6 percent.

May 5, 2023 12:07 IST
Centrum, Centrum India, Haleon, Haleon India, GSK, gummies market, healthcare news,
Centrum launches specialised nutritious gummies in India

The company claims that the brand is trying to recognise the emerging nutrition gaps Indian consumers face daily due to…

April 13, 2023 11:01 IST
GSK, Pfizer, Sanofi, Zantac, cancer, health news, pharma news,
GSK, Pfizer, Sanofi get relief after court found claims of Zantac-linked cancer not ‘backed by science’

Zantac, first approved in 1983, became the world’s best-selling medicine in 1988 and one of the first-ever drugs to top…

December 7, 2022 15:06 IST
GSK, Pfizer, Sanofi, Zantac, cancer, health news, pharma news,
GSK’s blood cancer drug fails main trial goal, shares fall

As oncology is a key area of focus for GSK as a standalone prescription medicine and vaccine business, the company’s…

November 7, 2022 16:04 IST
GSK, otilimab, investigational monoclonal antibody, Rheumatoid Arthritis (RA), Health news, pharma news,
GSK to skip regulatory submissions for its investigational drug

Rheumatoid Arthritis (RA) is a chronic, systemic inflammatory condition characterised by pain, joint swelling, stiffness, joint destruction and disability.

October 27, 2022 15:02 IST
  • Next »

Related News

Nvidia rules out Jensen Huang comeback
Nvidia rules out Jensen Huang comeback despite Trump, Musk backing ‘return campaign’
Jefferies top buys nov 16
8 ‘Buy’ recommendations by Jefferies with 16% to 49% upside potential
Overall, HVDC creates a strong project pipeline for companies with established technology, manufacturing capabilities and execution experience.
Rs 2.6 lakh cr transmission pipeline: 2 multinational stocks with Rs 20,000 cr+ order books
Restaurant
Jaipur restaurant told to pay Rs 10,000 for charging extra 50 paise from customer
After the recent correction, the valuation multiple of both these companies have become more reasonable.
Down over 20%: 2 footwear stocks with 20%+ ROCE and double-digit sales growth
shorts
Battery scrap export ban tests India’s refining capacity, raises pricing concerns
Battery scrap export ban tests India’s refining capacity, raises pricing concerns
Policy

India’s ban on lithium-ion battery black mass exports aims to expand domestic critical-mineral refining, backed by capacity that exceeds current end-of-life battery volumes. But only about 10% of recovered salts were battery-grade in 2025, and investment in technology and scale remains crucial.

View all shorts

Trending Topics

defence stocks
Gold rate today
Silver rate today
AI stocks
mutual funds
semiconductor stocks

Top Categories
  • Market
  • India News
  • Stock Insights
  • Money
  • Opportunities Abroad
  • World News
  • Latest News
  • Technology
  • ITR Guide
  • Money Insights
Stock Screeners
  • Stock Screener
  • Break Out Stocks
  • Defence Stocks
  • Consistently Growing Stocks
  • Low Price Blue Chip Stocks
Top NSE/BSE Companies Share Price
  • Tata Motors share price
  • Tata Steel share price
  • State Bank Of India share price
  • HDFC Bank share price
  • Infosys share price
  • ITC share price
  • Wipro share price
  • NTPC share price
  • ongc share price
  • Adani Enterprises share price
  • Adani Ports and Special Economic Zone share price
  • Bharat Petroleum Corporation share price
  • Coal India share price
  • Bajaj Finance share price
  • ICICI Bank share price
  • Titan Company share price
  • Larsen & Toubro share price
  • Power Grid Corporation Of India share price
  • Asian Paints share price
Gold Price in Top Metro Cities
  • Gold Rate Today
  • Gold Rate in Dubai
  • Gold Rate in Chennai
  • Gold Rate in Kerala
  • Gold Rate in Hyderabad
  • Gold Rate in Bangalore
  • Gold Rate in Mumbai
  • Gold Rate in Noida
  • Gold Price in Delhi
  • Gold Price in Ahmedabad
  • Gold Price in Kolkata
Latest News
  • FIIs buy Rs 4,865 crore while DIIs sell: 3 factors supporting market sentiment
  • Follow listing norms, RBI tells Tata Sons
  • Cutting chai and Tendulkar’s wicket : Prince William, Kate’s first day in Mumbai
  • Battery scrap export ban tests India’s refining capacity, raises pricing concerns
  • Stay committed to fiscal prudence, focus on jobs: Economists
Follow Us
  • Facebook Facebook Link
  • Twitter Twitter Link
  • Linkedin Linkedin Link
Download Apps
  • Play_stor Play_stor Link
  • Apple_stor Apple_stor Link
Indian Express Group
  • INDIAN EXPRESS GROUP
  • The Indian Express
  • Loksatta
  • Jansatta
  • Inuth
  • Ramnath Goenka Awards
  • Indian Express Hindi
  • IE Tamil
  • IE Malayalam
  • IE Bangla
  • IE Gujarati
  • Express Tributes
  • This website follows the DNPA’s code of conduct
Quick Links
  • T&C
  • Privacy Policy
  • CONTACT US
  • About Us
Copyright © 2026 The Indian Express [P] Ltd. All Rights Reserved
Market Pulse